Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Reexam of 148

Reexam of 148

posted on Dec 17, 2009 08:31AM

Most interesting. The examiner is asking for Kajiaya, Tanimura and Bugala to be argued again, even though they were argued in a 3/27/09 response. Odd indeed. Does this mean that the 3/27/09 argument was rejected? Since no mention is made to the 3/27 response/argument I must assume that he forgot? Perhaps he wants to keep secret his view on what a processing unit is?

I would think that we ought to demand some kind of reply to the 3/27 response before arguing the same prior art again. ????????

Am I misreading the office action? Anyone have any thoughts on the above?

GLTA, Opty

Share
New Message
Please login to post a reply